EconTalk cover image

Sam Peltzman on Regulation

EconTalk

00:00

Delay costs outweigh benefits

Sam argues the decade-long testing delays kill more than they save and that the biggest cost is postponed access to effective drugs.

Play episode from 29:33
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app